Chinese Medtech Companies Surge in Western Markets: 2026

Chinese medical technology companies are mounting a serious challenge to Western giants as Mindray and United Imaging Healthcare accelerate growth in Europe and the United States. Once viewed mainly as low-cost manufacturers, these firms now compete directly with Philips, Siemens Healthineers, and GE Healthcare in advanced imaging and patient monitoring, according to the Dutch financial daily FD. Analysts expect the foreign growth of Chinese medtech companies to continue in the near term.

Background: China's Medtech Industry Goes Global

For years, Chinese medical device makers focused on the domestic market, the world's second largest. But a combination of domestic price cuts, centralized procurement policies, and slowing home-market growth has pushed companies abroad. The result is a new wave of Chinese medtech expansion now visible in European and American hospitals. This shift also reflects the broader Chinese medical technology innovation wave that has transformed smartphones, electric vehicles, and now healthcare equipment.

How Mindray and United Imaging Are Growing Abroad

Mindray's International Surge

Shenzhen-based Mindray, China's largest medical device maker, reached a historic milestone in 2025: for the first time, its international revenue exceeded domestic revenue. International sales totaled ¥17.65 billion (about 53% of total revenue), while China contributed ¥15.63 billion. The momentum continued into Q1 2026, when international revenue grew 15.7% year over year, with Europe expanding more than 25%. "Mindray's overseas business has become the main growth engine," one industry analyst told FD. This overseas pivot reduces the company's exposure to Chinese policy risk and positions it as a direct rival to established Western players.

United Imaging's Global Push

Shanghai-based United Imaging Healthcare, a specialist in CT, MRI, and PET systems, is also expanding rapidly in the United States and Europe. In 2026, United Imaging deepened its partnership with German pharma and diagnostics giant Bayer, strengthening its distribution and service capabilities in key Western markets. United Imaging's focus on high-end imaging puts it in direct competition with Siemens Healthineers and GE Healthcare, two companies that have long dominated the global imaging market.

Impact on Philips, Siemens Healthineers, and GE Healthcare

The rise of Chinese medical technology companies is not just a story about market share; it is forcing Western incumbents to rethink pricing, supply chains, and innovation. The competition is particularly intense in patient monitoring and imaging, where Chinese products often undercut rivals on price while offering increasingly comparable quality. As a result, European and US hospitals now have more choice—and more negotiating power. This competitive pressure is also reshaping European hospital procurement strategies.

What Analysts Expect for 2026 and Beyond

Analysts expect the foreign growth of Chinese medtech companies to continue in the near term. The drivers include China's 15th Five-Year Plan, which emphasizes technology and innovation, and the growing acceptance of Chinese devices in emerging and developed markets. However, challenges remain, including regulatory hurdles, data security concerns, and geopolitical tensions that could affect procurement decisions in the West. Still, the trajectory is clear: Chinese medical technology companies are no longer just suppliers of low-cost components; they are becoming full-service competitors in the global healthcare market.

FAQ

Which Chinese medtech companies are expanding in Western markets?

Mindray and United Imaging Healthcare are leading the expansion, with significant growth in Europe and the United States.

How fast is Mindray growing internationally?

Mindray's international revenue reached 53% of total sales in 2025 and grew 15.7% year over year in Q1 2026, with Europe up more than 25%.

What does United Imaging Healthcare do?

United Imaging makes CT, MRI, and PET systems and partners with Bayer to expand in Western markets.

Who are the main Western competitors affected?

Philips, Siemens Healthineers, and GE Healthcare face the most direct competition in imaging and patient monitoring.